Trial record 1 of 1 for:    NCT01326871
Previous Study | Return to List | Next Study

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01326871
Recruitment Status : Unknown
Verified April 2016 by Altor BioScience.
Recruitment status was:  Active, not recruiting
First Posted : March 31, 2011
Last Update Posted : April 13, 2016
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Altor BioScience

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : July 2017
  Estimated Study Completion Date : October 2017